SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Alfacell (ACEL)
ACEL 11.54-0.9%Jan 16 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tom DuBois who wrote (1412)6/23/1998 12:37:00 PM
From: Gil Kempenich  Read Replies (1) of 1533
 
Tom,

Once the FDA gives the go-ahead for NDA filing, the likelihood of agreements goes up. Once NDA is filed, it goes up some more. With FDA approval, it goes up even more. However by then I would expect an agreement in place. I also expect investor interest to go up in the same way.

Institutions and pharma companies are all waiting for results, to reduce risk. Makes lots of sense. There is no incentive at this point for pharmas to come ot the plate, when we are so close to a reduced risk situation.

Gil

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News